| Evaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety. | |
| | |
MedLine Citation:
|
PMID: 20631047 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recently, glucagon-like peptide 1 (GLP1) and glucose-dependent insulinotropic polypeptide (GIP) have received much attention regarding possible roles in aetiology and treatment of type 2 diabetes. However, peptides co-secreted from the same enteroendocrine cells are less well studied. The present investigation was designed to characterise the in vitro and in vivo effects of xenin, a peptide co-secreted with GIP from intestinal K-cells. We examined the enzymatic stability, insulin-releasing activity and associated cAMP production capability of xenin in vitro. In addition, the effects of xenin on satiety, glucose homoeostasis and insulin secretion were examined in vivo. Xenin was time dependently degraded (t(1/2)=162±6 min) in plasma in vitro. In clonal BRIN-BD11 cells, xenin stimulated insulin secretion at 5.6 mM (P<0.05) and 16.7 mM (P<0.05 to P<0.001) glucose levels compared to respective controls. Xenin also exerted an additive effect on GIP, GLP1 and neurotensin-mediated insulin secretion. In clonal β-cells, xenin did not stimulate cellular cAMP production, alter membrane potential or elevate intra-cellular Ca(2)(+). In normal mice, xenin exhibited a short-acting (P<0.01) satiety effect at high dosage (500 nmol/kg). In overnight fasted mice, acute injection of xenin enhanced glucose-lowering and elevated insulin secretion when injected concomitantly or 30 min before glucose. These effects were not observed when xenin was administered 60 min before the glucose challenge, reflecting the short half-life of the native peptide in vivo. Overall, these data demonstrate that xenin may have significant metabolic effects on glucose control, which merit further study. |
| | |
Authors:
|
Ashley I Taylor; Nigel Irwin; Aine M McKillop; Steven Patterson; Peter R Flatt; Victor A Gault |
Related Documents
:
|
16228047 - Glucagon-like peptide-1 derivatives and dipeptidyl peptidase-iv inhibitors. new hope fo... 18525067 - Beyond glycemic control: the effects of incretin hormones in type 2 diabetes. 10828847 - Improved glycaemic control in obese diabetic ob/ob mice using n-terminally modified gas... 18849357 - Cnto736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistan... 20958207 - Prevention of type 2 diabetes by dietary patterns: a systematic review of prospective s... 7173597 - Effects of chlorpromazine on plasma glucose kinetics and concentration of long chain fa... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-07-14 |
Journal Detail:
|
Title: The Journal of endocrinology Volume: 207 ISSN: 1479-6805 ISO Abbreviation: J. Endocrinol. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-15 Completed Date: 2010-10-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375363 Medline TA: J Endocrinol Country: England |
Other Details:
|
Languages: eng Pagination: 87-93 Citation Subset: IM |
Affiliation:
|
SAAD Centre for Pharmacy and Diabetes, School of Biomedical Sciences Research Institute, University of Ulster, Coleraine, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood Glucose / metabolism* Cell Line Eating / drug effects, physiology Gastrointestinal Hormones / administration & dosage, pharmacology*, physiology* Insulin / secretion* Insulin-Secreting Cells / drug effects, secretion Mice Neurotensin / administration & dosage, pharmacology*, physiology* Protein Stability Satiety Response / drug effects*, physiology* Signal Transduction / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Gastrointestinal Hormones; 11061-68-0/Insulin; 144092-28-4/xenin 25; 39379-15-2/Neurotensin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The Effect Of GH and IGF-1 On Linear Growth and Skeletal Development and Their Modulation By SOCS Pr...
Next Document: Nutritional and environmental factors affecting plasma ghrelin and leptin levels in rats.